Fortis Healthcare shares slump 13%
Fortis Healthcare shares slumped 12.96% after Malaysia's IHH Healthcare Berhad said it is not concluding any negotiations to buy controlling stake in Fortis
New Delhi: Shares of Fortis Healthcare slumped nearly 13% on Friday after Malaysia’s IHH Healthcare Berhad said it is not close to “concluding any negotiations" to buy controlling stake in the company. The stock dived 12.96% to settle at ₹ 172.30 on BSE. During the day, it tanked 13.66% to ₹ 170.90.
At NSE, shares of the company dropped 12.83% to close at ₹ 172.50. The company’s market valuation also fell by ₹ 1,315 crore to ₹ 8,932.99 crore.
On the volume front, 28.69 lakh shares of the company were traded on BSE and over 2 crore shares changed hands at NSE during the day.
The company, however, maintained that it is constantly evaluating growth opportunities in select geographies in Asia including India, which is its fourth “home market".
According to media reports, the company, which was earlier speculated to have been in advanced talks with the Singh brothers—Malvinder and Shivinder—to acquire controlling stake in Fortis Healthcare and SRL Diagnostics, has pulled out of the talks.
“IHH is not, nor is it close to, concluding any negotiations or due diligence or transactions in India at this point in time," IHH Healthcare Berhad said in a filing to Bursa Malaysia.
Fortis Healthcare, which has already got shareholders’ nod to raise up to Rs5,000 crore, has maintained that it was still evaluating the best possible way to raise the funds and no firm decision has been approved by the board till date.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!